Effects of genetic engineering on the pharmacokinetics of antibodies.
about
High affinity mouse-human chimeric Fab against hepatitis B surface antigen.Development and characterization of a human single-chain antibody fragment against claudin-3: a novel therapeutic target in ovarian and uterine carcinomas.Generation of novel single-chain antibodies by phage-display technology to direct imaging agents highly selective to pancreatic beta- or alpha-cells in vivo.Construction and characterization of a novel fusion protein MG7-scFv/SEB against gastric cancer.Functional production and characterization of a fibrin-specific single-chain antibody fragment from Bacillus subtilis: effects of molecular chaperones and a wall-bound protease on antibody fragment production.124I-labeled engineered anti-CEA minibodies and diabodies allow high-contrast, antigen-specific small-animal PET imaging of xenografts in athymic miceSite specific discrete PEGylation of (124)I-labeled mCC49 Fab' fragments improves tumor MicroPET/CT imaging in mice.Cancer radioimmunotherapy.Protein-based tumor molecular imaging probes.Recombinant bispecific monoclonal antibodies prepared by the dock-and-lock strategy for pretargeted radioimmunotherapy.
P2860
Q33232511-CE188AEC-00C2-451D-A7FD-AB766ABC5696Q33442189-161A68FE-BB3A-4C8C-9F0F-DED647D44AA1Q33480823-61A653AB-07AD-4487-A986-1728E5EE18DEQ33746766-CD315D7B-9D4E-4E5C-9C31-4FCBD0EB91BCQ34101697-F7C43223-247D-4759-A25E-35AF68A5EC06Q34206802-F9E59E14-78BA-4837-BA4E-F8B3A02FE745Q34555580-2917FFE6-BEE7-4274-AEB8-A888277DC003Q35070045-962E31B2-8341-4961-852F-BD0309E80C08Q36742911-3D49E950-2461-406A-AF08-AF1455224951Q37720857-79BD09AF-5604-42D1-96CB-D4231C9EEA01
P2860
Effects of genetic engineering on the pharmacokinetics of antibodies.
description
1999 nî lūn-bûn
@nan
1999 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի հունիսին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Effects of genetic engineering on the pharmacokinetics of antibodies.
@ast
Effects of genetic engineering on the pharmacokinetics of antibodies.
@en
type
label
Effects of genetic engineering on the pharmacokinetics of antibodies.
@ast
Effects of genetic engineering on the pharmacokinetics of antibodies.
@en
prefLabel
Effects of genetic engineering on the pharmacokinetics of antibodies.
@ast
Effects of genetic engineering on the pharmacokinetics of antibodies.
@en
P2093
P1476
Effects of genetic engineering on the pharmacokinetics of antibodies
@en
P2093
P304
P577
1999-06-01T00:00:00Z